Quick Search

 

 


 

 

Result Summary for 114073

Result Summary
Protocol ID: 114073
Clinical Study ID: LOC114073
Official Title: Randomized, two-period, cross-over, bioequivalence study on tamsulosin hydrochloride 0,4 mg prolonged release hard gelatin capsule versus SECOTEX® (tamsulosin hydrochloride) 0,4 mg prolonged release hard gelatin capsule healthy male volunteers under fed conditions
Phase: phase 1
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: tamsulosin
Trade/Product Name: SECOTEX®, Synthon BV
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.